Clinical Trial

Safety and Preliminary Activity of BI115 in Advanced SCLC

Name: Safety and Preliminary Activity of BI115 in Advanced SCLC — clinical trial record (NCT07559019)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study is a multi-regional, open-label phase I study to evaluate the Safety, Tolerability, and Efficacy of IBI115 as Monotherapy and in Combination Therapy in Participants with Advanced Small Cell Lung Cancer

Protocol Amendment History 1 change

critical Recruitment opened 2026-06-05

Trial Details

NCT Number	NCT07559019
Lead Sponsor	Innovent Biologics (Suzhou) Co. Ltd.
Conditions	Small Cell Lung Cancer (SCLC)
Enrollment	150 participants
Start Date	2026-05-21
Primary Completion	2028-02-29 (estimated)
Study Completion	2030-03-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-04